Intra-aortic balloon pump in STEMI patients with cardiogenic shock Review article
Article Sidebar
Main Article Content
Abstract
Cardiogenic shock complicates 6–10% of all cases of STEMI and remains a leading cause of death, with hospital mortality rates approaching 50%. Management of cardiogenic shock in patients with acute myocardial infarction includes haemodynamic stability, achieved with medical therapy, emergent revascularization and mechanical circulatory support. IABP (intra-aortic balloon pumping) counterpulsation is the most widely used mechanical support for the treatment of cardiogenic shock, but new data shows, that IABP is not effective in patient with STEMI with cardiogenic shock who are undergoing primary PCI. In that article, indication, contraindication for IABP, complication of this method and results of new clinical study with IABP are discussed.
Article Details
Copyright © by Medical Education. All rights reserved.
References
2. Kantrowitz A., Cardona R.R., Au J. et al.: Intraaortic balloon pumping in congestive failure. W: Congestive heart failure pathophysiology, diagnosis and comprehensive approach to management. Hosenpud J., Greenberg B. (red.). Springer-Verlag 1994; 28: 522-547.
3. Grupa Robocza Europejskiego Towarzystwa Kardiologicznego do spraw postępowania w ostrym zawale serca z uniesieniem odcinka ST. Postępowanie w ostrym zawale serca z utrzymującym się uniesieniem odcinka ST. Kardiologia Polska 2009; 67: 1 (supl. 2).
4. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal 2012; 33: 2569-2619.
5. Olasińska-Wiśniewska A., Mularek-Kubzdela T., Grajek S. et al.: Indications, results of therapy and factors which influence survival in patients treated with intra-aortic balloon counterpulsation. Kardiol. Pol. 2008; 66: 950-955.
6. Karcz M., Rużyłło W.: Interwencyjne leczenie ostrego zawału serca z uniesieniem odcinka ST. W: Kardiologia interwencyjna. Brzezińska-Rajszys G., Dąbrowski M., Rużyłło W., Witkowski A. (red.). Wydawnictwo Lekarskie PZWL, Warszawa 2009.
7. Sanborn T.A., Sleeper L.A., Bates E.R. et al.: Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock? J. Am. Coll. Cardiol. 2000; 36: 1123-1129.
8. Magnus Ohman E., Nanas J., Stomel R.J. et al.: Thrombolysis and Counterpulsation to Improve Survival in Myocardial Infarction Complicated by Hypotension and Suspected Cardiogenic Shock or Heart Failure: Results of the TACTICS Trial. J. Thromb. Thrombolysis 2005; 19: 33-39.
9. Barron H.V., Every N.R., Lori S. et al. for the Investigators in the National Registry of Myocardial Infarction 2. The Use of Intra-Aortic Balloon Counterpulsation in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction: Data From the National Registry of Myocardial Infarction 2. Am. Heart J. 2001; 141: 933-939.
10. Thiele H. et al.: Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock. N. Engl. J. Med. 2012; 367(14): 1287-1296.